...
首页> 外文期刊>ChemMedChem >Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin
【24h】

Design and Synthesis of Bioisosteres of Acylhydrazones as Stable Inhibitors of the Aspartic Protease Endothiapepsin

机译:酰腙生物异构糖剂的设计与合成天冬氨酸蛋白酶稳定抑制剂

获取原文
获取原文并翻译 | 示例

摘要

Acylhydrazone-based dynamic combinatorial chemistry (DCC) is apowerful strategy forthe rapid identification of novel hits. Even though acylhydrazones are important structural motifs in medicinal chemistry,their further progression in development may be hampered by major instabilityand potentialtoxicity under physiological conditions. It is therefore of paramount importance to identify stable replacements for acylhydrazone linkers. Herein, we presentthe first reportonthe design and synthesis of stable bioisosteres of acylhydrazone-basedinhibi- tors of the aspartic protease endothiapepsin as afollow-up to aDCC study.The mostsuccessful bioisostere is equipotent, bears an amide linker,and we confirmed its binding mode by X-ray crystallography.Having some validated bioisosteres of acylhydrazones readily available might accelerate hit-to-lead optimization in future acylhydrazone-based DCC projects.
机译:基于酰基的动态组合化学(DCC)是卓越的策略,快速识别新颖的命中。 尽管酰基腙是药用化学中的重要结构基质,但它们在生理条件下主要不含不含潜在的发育进一步的发展进程可能会受到阻碍。 因此,对于酰腙接头识别稳定的替代,因此重要的是至关重要的。 在此,我们介绍了第一个报告者的设计和合成亚烷基腙内皮内植物的稳定生物蛋白剂的稳定生物蛋白酶,如Adcard蛋白酶内植物的替代症。均匀的生物驾驶员是等待的,携带酰胺链接器,并通过X确认其绑定模式 -Ray晶体学。随时可用的一些经过验证的酰基腙的生物蛋白剂可能会加速未来基于酰腙的DCC项目的抗铅优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号